Strategies for chronic coronary disease: A brief guide for clinicians

The 2023 Multisociety Guidelines for the Management of Patients with Chronic Coronary Disease (CCD) is a collaborative effort between the American Heart Association (AHA) and the American College of Cardiology (ACC) that provides recommendations on the management of this condition. Efficient management of CCD involves non-pharmaceutical interventions that promote healthier lifestyles, such as increasing physical activity, adopting a balanced diet, and addressing tobacco misuse. These changes are critical to improving cardiovascular outcomes for individuals with CCD. In addition to lifestyle modifications, pharmacological and revascularization treatments also play an essential role in managing CCD. These treatments target the complex mechanisms of the disease, optimize cardiac function, and decrease the risk of adverse events. The combination of lifestyle changes and medicine-based medications enhances the quality of life and lowers mortality rates among individuals with CCD. This article review emphasizes the importance of non-pharmacological and pharmacological strategies that align with the AHA/ACC guidelines. In addition, the primary objective of this study is to enhance comprehension of the approaches that have led to better cardiovascular results for patients diagnosed with CCD.